Immunosuppressed Patients and the Dental Team
Course Description
As more patients present with transplant medications, biologics, chemotherapy adjuncts, and other immune-modifying therapies, the dental team is being asked to make more nuanced clinical decisions than ever before. In this podcast-style session, Drs. Tom Viola and Kelly Tanner explore how immunosuppression can affect infection risk, healing, treatment timing, and the decision to move forward with or postpone elective care. Through an engaging back-and-forth format, they connect complex medical considerations to the real-world questions dental teams face every day, from documentation and communication to patient safety and treatment planning. Attendees will leave with a stronger understanding of how immunosuppression can shift routine care and what it means to treat these patients with greater confidence and clinical clarity.
Learning Objectives
- Identify common categories of immunosuppressive therapies and their potential implications for infection risk, healing, and dental treatment planning.
- Evaluate how treatment timing, medical history, and patient-specific risk factors may influence decisions regarding routine care, invasive procedures, and elective treatment.
- Describe the role of the dental team in recognizing, documenting, and communicating risk factors that support safer, patient-centered care for immunosuppressed individuals.
CE Credits: 1
Please check your spam folder!
System Requirements:
-
- PC, Mac, Laptop, and other mobile devices with standard web browser capability.
- The newest version of Google Chrome, Firefox, or Safari browsers.
- Internet connection with 500+Kbps
This course is non-refundable
